Cargando…

Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology

Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested.

Detalles Bibliográficos
Autores principales: Chepurnov, A. A., Kazachinskaya, E. I., Kazachkova, E. A., Sharshov, K. A., Kononova, Yu. V., Shelemba, A. A., Alekseev, A. Yu., Gulyeva, M. A., Voevoda, M. I., Shestopalov, A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596366/
https://www.ncbi.nlm.nih.gov/pubmed/34787781
http://dx.doi.org/10.1007/s10517-021-05329-7
_version_ 1784600347495366656
author Chepurnov, A. A.
Kazachinskaya, E. I.
Kazachkova, E. A.
Sharshov, K. A.
Kononova, Yu. V.
Shelemba, A. A.
Alekseev, A. Yu.
Gulyeva, M. A.
Voevoda, M. I.
Shestopalov, A. M.
author_facet Chepurnov, A. A.
Kazachinskaya, E. I.
Kazachkova, E. A.
Sharshov, K. A.
Kononova, Yu. V.
Shelemba, A. A.
Alekseev, A. Yu.
Gulyeva, M. A.
Voevoda, M. I.
Shestopalov, A. M.
author_sort Chepurnov, A. A.
collection PubMed
description Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested.
format Online
Article
Text
id pubmed-8596366
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85963662021-11-17 Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology Chepurnov, A. A. Kazachinskaya, E. I. Kazachkova, E. A. Sharshov, K. A. Kononova, Yu. V. Shelemba, A. A. Alekseev, A. Yu. Gulyeva, M. A. Voevoda, M. I. Shestopalov, A. M. Bull Exp Biol Med Virology Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested. Springer US 2021-11-17 2021 /pmc/articles/PMC8596366/ /pubmed/34787781 http://dx.doi.org/10.1007/s10517-021-05329-7 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Virology
Chepurnov, A. A.
Kazachinskaya, E. I.
Kazachkova, E. A.
Sharshov, K. A.
Kononova, Yu. V.
Shelemba, A. A.
Alekseev, A. Yu.
Gulyeva, M. A.
Voevoda, M. I.
Shestopalov, A. M.
Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title_full Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title_fullStr Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title_full_unstemmed Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title_short Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
title_sort development of a purified viral preparation for studies of covid-19 (sars-cov-2) biology
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596366/
https://www.ncbi.nlm.nih.gov/pubmed/34787781
http://dx.doi.org/10.1007/s10517-021-05329-7
work_keys_str_mv AT chepurnovaa developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT kazachinskayaei developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT kazachkovaea developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT sharshovka developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT kononovayuv developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT shelembaaa developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT alekseevayu developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT gulyevama developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT voevodami developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology
AT shestopalovam developmentofapurifiedviralpreparationforstudiesofcovid19sarscov2biology